Search results (42)
« Back to PublicationsAn adenoviral-vectored vaccine protects mice against aerosol challenge with Yersinia pestis.
Dold C. et al, (2026), Molecular therapy : the journal of the American Society of Gene Therapy, 34, 3518 - 3534
Interventions for the control of Crimean-Congo hemorrhagic fever and tick vectors.
de la Fuente J. et al, (2024), NPJ vaccines, 9
Immunogenicity of PvCyRPA, PvCelTOS and Pvs25 chimeric recombinant protein of Plasmodium vivax in murine model.
Matos ADS. et al, (2024), Frontiers in immunology, 15
Antibody evasion by the P.1 strain of SARS-CoV-2
Dejnirattisai W. et al, (2021), Cell, 184, 2939 - 2954.e9
The antigenic anatomy of SARS-CoV-2 receptor binding domain
Dejnirattisai W. et al, (2021), Cell, 184, 2183 - 2200.e22
Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera
Supasa P. et al, (2021), Cell, 184, 2201 - 2211.e7
Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera
Zhou D. et al, (2021), Cell, 184, 2348 - 2361.e6
Adenoviral-Vectored Mayaro and Chikungunya Virus Vaccine Candidates Afford Partial Cross-Protection From Lethal Challenge in A129 Mouse Model
Campos RK. et al, (2020), Frontiers in Immunology, 11
Broad and strong memory CD4+ and CD8+ T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19
Peng Y. et al, (2020), Nature Immunology, 21, 1336 - 1345
Detection of neutralising antibodies to SARS-CoV-2 to determine population exposure in Scottish blood donors between March and May 2020
Thompson CP. et al, (2020), Eurosurveillance, 25
Recombinant Plasmodium vivax circumsporozoite surface protein allelic variants: antibody recognition by individuals from three communities in the Brazilian Amazon.
Soares IF. et al, (2020), Scientific reports, 10
Antibody testing for COVID-19: A report from the National COVID Scientific Advisory Panel
Adams ER. et al, (2020), Wellcome Open Research, 5, 139 - 139